Abstract
Introduction
Whole brain radiation therapy (WBRT) remains a recommended treatment for patients with brain metastases in terms of symptom palliation, especially when extracranial systemic disease is present. The aim of the study was to determine the clinical correlation between pre-existing leukoaraiosis and posterior leukoencephalopathy secondary to WBRT.
Methods and Materials
We retrospectively reviewed the results of WBRT treatment in 44 patients with melanoma brain metastases. The neuroimaging abnormalities of the white matter (T2-weighted MRI) were graded over time. Results: From the 37 evaluable patients the mean age was 53 years old, 23 male and 14 female. Vascular risk factors were present in 22 patients (59.5%). The WBRT total dose was 20 Gy/5fr (n=21) and 30 Gy/10fr (n=16). Leukoaraiosis pre-WBRT was observed in 9/37 patients (24.3%) and leukoencephalopathy post-WBRT in 2/37 (5.4%). Univariate analysis of prognostic factors (sex, age and vascular risk factors) for leukoaraiosis was conducted observing statistically significant differences for patients with age ≥65 years old (p=0.003). Nineteen patients survived more than 3 months. Twelve patients (63.2%) suffered from vascular risk factors. Univariate analysis demonstrated previous leukoaraiosis as a prognostic factor for developing further leukoencephalopathy after WBRT (p=0.015).
Conclusions
Radiation-induced leukoencephalopathy is greater in patients with pre-existing leukoaraiosis. Because of the potential of long-term survival in a small subset of patients with brain metastases and the risk of radiation-induced dementia, neurotoxicity reduction in patients with leukoaraiosis is an important goal of treatment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Madajewicz S, Karakousis C, West CR et al (1984) Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 53:2550–2552
Chao JH, Phillips R, Nickson JJ (1954) Roentgen-ray therapy of cerebral metastases. Cancer 7:682–689
Carella RJ, Gelber R, Hendrickson F et al (1980) Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: Radiation Therapy Oncology Group Brain Metastases Study I and II. Cancer 45:679–683
Buchsbaum JC, Suh JH, Lee S-Y et al (2002) Survival by Radiation Therapy Oncology Group Recursive Partitioning Analysis Class and treatment modality in patients with brain metastases from malignant melanoma. A retrospective study. Cancer 94:2265–2272
Franke W, Neumann N, Richter-Hintz D et al (2000) Temozolomide — A promising agent in the therapy of brain metastases in malignant melanoma. In: American Society of Clinical Oncology 36th Annual Meeting, New Orleans, 20–23 May. Prog Proc Am Soc Clin Oncol 19:575
Biasco G, Pantaleo MA, Casadei S (2001) Treatment of brain metastases of malignant melanoma with temozolomide. N Engl J Med 345:621
Conill C, Puig S, Toscas I, Castel T (2002) Complete response of cerebral metastatic melanoma after a combined treatment of radiotherapy and temozolomide. Med Clin (Barc) 119:758–759
Conill C, Fernandez-Ibiza J, Malvehy J et al (2004) Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation. Med Clin (Barc) 122:413–415
Crossen JR, Garwood D, Glastein E, Neuwelt EA (1994) Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12:627–642
Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1:634–656
Conill C, Verger E, Salamero M (1990) Performance status assessment in cancer patients. Cancer 65:1864–1866
Gaspar LE, Scott Ch, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001–1006
Zimmerman RD, Fleming CA, Lee BCP et al (1986) Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance. AJNR Am J Neuroradiol 7:13–20
Tsuruda JS, Kortman KE, Bradley WG et al (1987) Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol 1987; 149:165–71
Vigliani MC, Duyckaerts C, Hauw JJ et al (1999) Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J Neuro-Oncol 41:137–149
Corn BW, Yousem DM, Scott CB et al (1994) White matter changes are correlated significantly with radiation dose. Cancer 74:2828–2835
Asai A, Matsutani M, Kohno T et al (1989) Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 63:1962–1974
DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796
Hochberg FH, Slotnick B (1980) Neuropsychologic impairment in astrocytoma survivors. Neurology 30:172–177
Fisher B, Seiferheld W, Schultz Ch et al (2005) Secondary analysis of Radiation Oncology Group Study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neuro-Oncol 74:201–205
Johnson BE, Becker B, Goff WB et al (1985) Neurologic, neuropsychologic, and computed tomography scan abnormalities in 2 to 10-year survivors of small cell carcinoma lung cancer. J Clin Oncol 3:1659–1667
Curran WJ, Hecht-Leavitt C, Schut L et al (1987) Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys 13:1093–1098
Regine WF, Scott C, Murray K, Curran W (2001) Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711–717
Shibamoto Y, Baba F, Oda K et al (2006) Incidence of brain atrophy and dementia after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys 66[Suppl 1]:S86–S87
Wassenberg MW, Bromberg JE, Witkamp TD et al (2001) White matter lesions and encephalopathy in patients treated for primary central nervous system lymphoma. J Neurooncol 52:73–80
Gruss C, Geissler A, Schalke B et al (2002) Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation. Melanoma Res 12:403–404
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conill, C., Berenguer, J., Vargas, M. et al. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 9, 590–595 (2007). https://doi.org/10.1007/s12094-007-0108-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-007-0108-2